NSI-189 Phosphate

Buy NSI-189 Phosphate Online

NSI-189 Phosphate is an investigational small molecule developed primarily for neurological and psychiatric research. It has attracted attention because of research suggesting effects on hippocampal neurogenesis and cognitive function.

Product Information

NSI-189 was developed as a neurogenic compound with particular interest in the hippocampus, a brain region strongly associated with memory and emotional processing. Early human research investigated its potential in major depressive disorder.

How It Works

NSI-189 appears to influence hippocampal neurogenesis and neuronal signaling rather than acting primarily through conventional antidepressant neurotransmitter pathways. Preclinical research suggests that increased hippocampal neurogenesis may contribute to its observed behavioral effects.

POTENTIAL BENEFITS

1. Supports Neurogenesis Research

NSI-189 has become particularly notable for research involving hippocampal neurogenesis. This makes it relevant to studies investigating how new neuronal growth may influence brain function.

2. Cognitive Function

Preclinical research has explored NSI-189 for potential improvements in learning and memory. Its hippocampal activity provides a compelling basis for continued cognitive research.

3. Mood-Related Research

Human clinical trials have investigated NSI-189 in major depressive disorder. Early findings generated interest in its potential as a novel approach to mood-related disorders.

4. Hippocampal Health

The hippocampus plays a central role in memory and emotional regulation. By influencing pathways associated with hippocampal neurogenesis, NSI-189 has become an important compound in experimental neuroscience.

Dosage

Human clinical trials have investigated NSI-189 at different daily doses, including 40 mg and 80 mg/day in depression research. These were controlled clinical-study doses and should not be interpreted as an established self-use regimen.

Side Effects

Reported clinical-study adverse effects have included headache, nausea, dizziness, gastrointestinal symptoms, and other nonspecific complaints.

References

1. PubMed - NSI-189 Phase 1B trial PubMed
2. PubMed - NSI-189 Phase 2 trial PubMed
3. PubMed - NSI-189 neurogenic effects PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.